Many with Allergies Don’t Know About Oral Immunotherapy Option

Nationally representative survey finds socioeconomic disparities in awareness of oral immunotherapy for food allergies
Many with Allergies Don’t Know About Oral Immunotherapy Option(Unsplash)
Many with Allergies Don’t Know About Oral Immunotherapy Option(Unsplash)

A study of a geographically, clinically, and socioeconomically diverse, nationally-representative sample of US households – including both adult patients and caregivers of children with food allergy – found that 72 percent did not know what oral immunotherapy (OIT) was prior to the survey. Researchers also discovered that current OIT awareness is disproportionately elevated among wealthier, more highly educated respondents, which underscores the need for more equitable outreach efforts and greater access to these therapies for all patients with food allergies. Findings were published in the Journal of Allergy and Clinical Immunology: In Practice.

Many with Allergies Don’t Know About Oral Immunotherapy Option(Unsplash)
Antibiotics in young kids can cause permanent asthma & allergies

Food allergy is a significant health concern affecting approximately 8 percent of children and 10 percent of adults in the U.S. Currently, recommended food allergy management involves strict avoidance of the offending food and ensuring ready access to epinephrine. This poses a great challenge for patients and families as it can impair quality of life, impose financial burdens, and potentially result in life threatening anaphylaxis following accidental ingestion.

Currently, recommended food allergy management involves strict avoidance of the offending food and ensuring ready access to epinephrine(Unsplash)
Currently, recommended food allergy management involves strict avoidance of the offending food and ensuring ready access to epinephrine(Unsplash)

In 2020, the FDA approved Palforzia®, a drug product from peanut flour, for use in OIT, making it the first approved treatment for patients with peanut allergy, ages 4-17 years.

Many with Allergies Don’t Know About Oral Immunotherapy Option(Unsplash)
What Happens When our Heart Experiences Blood Flow Reflux?

“With the ongoing expansion of oral immunotherapy offerings and additional therapies on the horizon, it is important to ensure equitable access to all treatments for food allergy,”

senior author Ruchi Gupta, MD, MPH, a pediatrician and food allergy researcher at Ann & Robert H. Lurie Children’s Hospital of Chicago and Professor of Pediatrics at Northwestern University Feinberg School of Medicine.

“The latest epidemiological data indicates that approximately half of US food-allergic children are either Black, Hispanic/Latinx, or multi-racial, populations which have historically encountered greater barriers to specialty care owing to lower socioeconomic status. It is critical that we reach these children and create greater awareness of oral immunotherapy, so that they too can benefit from recent advances in food allergy treatments.”

Surveys were completed by 781 respondents from all 50 states. Respondents were required to report a physician-diagnosed food allergy to be eligible for the study.

(LS/Newswise)

Join MedBound - an ecosystem for students and professionals of medical and health sciences.

Related Stories

No stories found.
Medbound
www.medboundtimes.com